On this page, you can find the information that we believe is both interesting and relevant to existing and potential investors in Audientes.
It includes company announcements, press releases, and our financial calendar, to ensure that you don’t miss out on any important news regarding the Audientes share.
Join us on our journey to make smart, self-fitting and affordable hearing aids available to the millions of people around the world suffering from disabling hearing loss.
Watch the video to learn more.
All announcements are also available in English as attachments to the documents below.
Don’t miss out on any of our upcoming events. In case you can’t make it, recordings of online events are also available below.
AKTIEINFO Danmark investor event
Audientes participated in this investor event, hosted by AKTIEINFO Danmark. Watch our CEO, Steen Thygesen present Audientes, our current momentum and the key reasons to invest.
Audientes at the Impact Seminar
Watch Audientes CEO share details on how Audientes is working to make an impact on disabling hearing loss – one of the biggest health challenges facing the world today.
Presentation of Audientes Q1 2021 Financial Report
Watch Audientes CEO, Steen Thygesen present our results for Q1 2021
Audientes deep dive on hearing aids and the India opportunity
Watch our CEO, Steen Thygesen present more details on our hearing aid and the opportunities presented by the Indian market, at this HC Andersen Capital-hosted event.
Audientes meets Unge Investorer
Watch Audientes CEO, Steen Thygesen’s presentation to young investors in the Facebook Group ‘Unge Investorer.’
Audientes at Small & Mid Cap Seminar, 31 March 2021
Watch Audientes A/S CEO, Steen Thygesen present Audientes at this recent event, hosted by HC Andersen Capital & Nordnet
Introduction to the Audientes Share
In case you missed it, here’s a recording of our Feb 4th webinar on The Audientes Share, hosted by HC Andersen Capital. Take a look and listen to Audientes CEO, Steen Thygesen provide an update on where we are today and what you can expect to hear from us in the coming months
Investor webinar with Audientes and Aktiespararna Sverige
Watch Audientes CEO, Steen Thygesen outline the Audientes share and our mission to make smart, self-fitting and affordable hearing aids accessible to the millions of people around the world who suffer from disabling hearing loss.
Audientes at the 2020 Small Cap Seminar
Watch our CEO, Steen Thygesen give a talk at the 2020 Small Cap Seminar, Audientes and our mission to bring smart, affordable and high-quality hearing aids to the millions of people around the world suffering from disabling hearing loss.
Steen has a bachelor degree in Electronics Engineering from Copenhagen’s Teknikum, and an MBA from London Business School. Throughout his 30-year career, both abroad and in Denmark, he has held positions at Star, Nokia Denmark A/S, Microsoft Inc., Symbian PLC, Psion Software PLC, CompuServe Inc. and TDC. He was also the Managing Director of Specialisterne Foundation, owner of the social economic enterprise, Specialisterne, where he led the establishment and growth of Specialisterne in 15 countries.
Hossein has an MA in Electric Engineering from Danmark’s Tekniske University. He began his career in Nokia in 1997 as a software engineer and held a number of roles, including Test Manager. In 2012, he founded the hearing aid research and development company, Jelveh Medical Device. In 2014, he founded Audientes.
Board of directors
Povl-André has a Masters of Science from CBS, and a long career in the life sciences industry, where he held several commercial and financial leadership positions. He holds a number of board positions, including Chairman of the Board for 2cureX AB, which is listed on the Nasdaq First North Sweden exchange.
Gitte has a degree in market economies and has more than 20 years of leadership experience within life sciences industries and has worked with strategic and commercial business development. She has held positions that include CFO, COO as well as Supply Chain Manager in pharmaceutical companies, Meda and Mylan. In connection with these, she has participated in several international M&A transactions. She currently holds the CEO position at UV Clinical.
Elsebeth has a university degree in Economics and has held numerous international positions within the life sciences industry, including international manager in GN Danavox A/S (now GN Resound), Director at Coloplast A/S as well as CEO of Danish Health Consult A/S. Additionally, she has been the Dean of the Bioanalyst Faculty in Copenhagen and Mentor at DTU Science Park, DeepTech mentoring since 2014.
Peter Røpke has an M.Sc. in Electrical, Electronics and Communications Engineering, from Danish Technical University, DTU (1992). He is currently President and CEO for RTX A/S, a Nasdaq Main Market, Mid Cap. company, listed on Nasdaq Nordic, that designs and develops wireless communication products across a wide range of applications. Peter has a long career behind him in product and technology development, manufacturing and consumer electronics. Peter has previously held senior positions at Flügger A/S, Grundfos Management A/S and Nokia Corporation.
Financial and legal documents
|August 19, 2021||Half-year 2021 reporting|
|November 18, 2021||Q3 2021 reporting|
|March 24, 2022||Annual Report 2021
|April 21, 2022||Annual General Meeting 2022|